Study Design
ischemic left ventricular dysfunction, arrhythmia, extensive coronary disease, decompensated heart failure
DECOMPENSATED HEART FAILURE, ARRHYTHMIA, VENTRICULAR ARRHYTHMIA, SEVERE LEFT VENTRICULAR SYSTOLIC DYSFUNCTION, FIBRILLATION
The trial design and primary outcome results have been reported previously.All participants enrolled in the REVIVED-BCIS2 trial were included in the present analyses. Patients were eligible for inclusion in the trial if they had ischemic left ventricular dysfunction, defined by the presence of severe left ventricular systolic dysfunction (left ventricular ejection fraction ≤35%), extensive coronary disease (British Cardiovascular Intervention Society Jeopardy Score ≥6), and evidence of viability in at least 4 dysfunctional myocardial segments that were amenable to revascularization with PCI. Those with myocardial infarction in the 4 weeks before randomization, sustained ventricular arrhythmia (ventricular tachycardia, ventricular fibrillation, or appropriate ICD discharges) in the 72 hours before randomization, or acutely decompensated heart failure were excluded.The statistical analysis plan for this arrhythmia substudy was finalized before unblinding of trial group data from the arrhythmia case report form and is included in the 